Mimi E. Vaughn
As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s principal accounting officer.
Highest-materiality recent filing
Genesco reports Q1 sales beat, raises FY2027 EPS outlook; launches $40-50M cost program
Net sales of $487M rose 3% YoY; comparable sales increased 2% with 3% same-store growth.
Genesco appoints Ashley Randolph as Chief Accounting Officer effective May 5, 2026
Ashley Randolph, 20-year company veteran and former VP/Corporate Controller, named VP and CAO.
Genesco adopts new Short-Term Incentive Plan for FY2027, replacing EVA Plan
STIP effective FY2027; replaces Fourth Amended and Restated EVA Plan.
Genesco CEO Mimi Vaughn adds principal accounting officer role after CFO departure
Cassandra E. Harris ceased as principal accounting officer effective March 25, 2026, after FY2026 10-K filing.
Journeys Group Q4 comp sales +12%; overall comps +9% (stores +9%, e-commerce +8%).
Genesco CFO Cassandra Harris resigns effective March 6; CEO Mimi Vaughn named interim CFO
Harris resigns to pursue non-retail opportunities; departure not related to any disagreement with the company.
Genesco extends credit facility maturity to Jan 2031, adjusts pricing grid
Fourth Amendment extends maturity of revolving credit facility to January 16, 2031.
Genesco Q4-to-date comparable sales +9% YoY; raises FY2026 adjusted EPS guidance to at least $1.30
Total comparable sales up 9% for the 8 weeks ended Dec 27, 2025; same-store sales +10%, e-commerce +9%.
Genesco Q3 sales +3% to $616M; adj EPS $0.79; cuts FY adj EPS guidance to ~$0.95
Q3 net sales $616M (+3% YoY); GAAP EPS $0.51 vs ($1.76); Non-GAAP EPS $0.79 vs $0.61.
Genesco Q2 net sales +4% to $546M, beats expectations; raises FY sales outlook
Q2 GAAP EPS ($1.79) vs ($0.91) last year; Non-GAAP EPS ($1.14) vs ($0.83); operating loss $14.4M.
Genesco shareholders elect all nine director nominees at 2025 annual meeting
All nine director nominees elected with votes ranging from ~6.5M to ~6.8M for each.
Genesco Q1 sales +4% YoY, comparable sales +5%; loss narrows; reiterates FY adj EPS $1.30-$1.70
Net sales $474M (+4% YoY); comparable sales +5% with Journeys +8%, Schuh +1%, J&MG -2%.
Genesco formally engages Deloitte & Touche as FY2026 independent auditor
Deloitte completed client acceptance procedures and was formally engaged on May 15, 2025.
Genesco dismisses EY as auditor, appoints Deloitte effective April 30, 2025
Audit Committee dismissed Ernst & Young LLP and appointed Deloitte & Touche LLP as independent auditor, effective April 30, 2025.
Genesco Q4 comparable sales +10%; adjusted EPS $3.26 beats prior year $2.59
Q4 net sales $746M (+1%); comparable sales +10% led by Journeys +14% and e-commerce +18%.
The amendments apply to certain executive officers, excluding CEO Mimi E. Vaughn and Parag D. Desai.
Genesco Q4-to-date comparable sales up 10% YoY; reaffirms FY25 EPS guidance
Quarter-to-date comparable sales (8 wks ended Dec 28, 2024) increased 10% vs prior year.
Genesco CFO Thomas George retires; Sandra Harris assumes principal accounting officer role
Thomas A. George retired as Senior VP, Finance and CFO effective December 12, 2024, as part of planned retirement.
Genesco beats Q3 expectations; raises FY2025 adjusted EPS guidance to $0.80-$1.00
Net sales $596M (+3% YoY); comparable sales +6% driven by Journeys +11% comp.
Genesco appoints Sandra Harris as CFO, replacing retiring Thomas George
Sandra Harris named CFO effective Oct 7, 2024, succeeds Thomas George who retires Dec 12.
Genesco Q2 net sales $525M, non-GAAP EPS ($0.83) vs ($0.85) YoY; reaffirms FY EPS $0.60-$1.00
GAAP operating loss $10.3M (2.0% of sales) vs $38.6M loss last year; adjusted operating loss $9.3M.
Genesco CFO Thomas George adds principal accounting officer role; CAO Baxter to resign July 31
Thomas A. George, CFO and SVP-Finance, appointed additional role of principal accounting officer.
Genesco shareholders elect all nine directors and approve all proposals at annual meeting
All nine director nominees elected, with 'for' votes ranging from ~8.35M to ~8.72M.
Genesco Q1 operating loss $32.1M; reaffirms FY2025 EPS guidance $0.60-$1.00
Net sales $458M (-5% YoY); comparable sales -5%; e-commerce +3% to 23% of retail sales.
Genesco increases share repurchase authorization by $50M to $250M
Existing $200M authorization: $189.5M used on 3.9M shares since Sep 2019, leaving $10.5M.
Genesco adopts Executive Severance Plan covering key officers with 12-24 month severance
Plan covers key management, including named executive officers, upon involuntary termination or good reason resignation.
Genesco Q4 non-GAAP EPS $2.59; FY24 GAAP loss; FY25 adj EPS guidance $0.60-$1.00
Q4 net sales $739M (+2% vs 13-wk prior year); comps down 4%; e-commerce 27% of retail.
As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s principal accounting officer.
On May 5, 2026, Genesco Inc. (the “Company”) announced the appointment of Ashley Randolph as Chief Accounting Officer and principal accounting officer.
On October 1, 2024, the Company also announced that Thomas A. George, Senior Vice President, Finance and Chief Financial Officer, will be leaving the Company as part of his planned retirement.
On October 1, 2024, Genesco Inc. (the “Company”) announced the appointment of Cassandra “Sandra” Harris as Senior Vice President, Finance and Chief Financial Officer of the Company, effective October 7, 2024
On June 27, 2024, Thomas A. George, Genesco Inc.’s (the “Company”) chief financial officer and senior vice president – finance, was appointed to serve in the additional role of the Company’s principal accounting officer
on June 27, 2024, Brently G. Baxter notified the Company that he will resign as the Company’s vice president and chief accounting officer effective July 31, 2024.
Max materiality 0.85 · Median 0.55 · Most common event earnings